Bonemas 70 mg tablets contain alendronic acid, a bisphosphonate that slows the cells which break down bone. It is used in the treatment of osteoporosis after menopause, where it helps increase bone mass and lower the chance of fractures.
There are 4 brands of Alendronic Acid listed in Bangladesh. By unit price, Bonemas is among the cheapest of them. The lowest listed price is Bonemas 10 mg Tablet at ৳ 30.00 per unit.
What is Bonemas 70 mg Tablet?
Bonemas is a tablet made by Incepta Pharmaceuticals Ltd. that contains alendronic acid 70 mg, a member of the bisphosphonate group of medicines. Bisphosphonates attach to bone and reduce the action of osteoclasts, the cells that break bone down, so bone loss is slowed. Bonemas is used for the treatment of osteoporosis in postmenopausal women; in this group it raises bone mass and lowers the number of fractures, including fractures of the hip and spine. It comes as tablets in a 10's pack. The doctor decides the dose and course. Ask your doctor or pharmacist if you are unsure whether this medicine suits you.
Uses of Bonemas
Bonemas is used to treat osteoporosis in women after menopause. In this condition, bone becomes weaker and breaks more easily. Alendronic acid works on the bone-removing cells and slows bone loss, and treatment has been shown to increase bone mass and reduce fractures of the hip and spine. It is not a painkiller and does not relieve symptoms you can feel. Your doctor will decide whether it is right for you and how long you should take it.
How to use Bonemas
Bonemas is a tablet that your doctor will tell you how to take. The dose and course are decided by your doctor, so follow their instructions exactly and do not change them on your own. The tablet is usually swallowed whole with plain water, and you should stay upright as your doctor advises. Do not take it with antacids or calcium supplements, as these reduce how much is absorbed. Ask your pharmacist if you are unsure about anything.
Side effects of Bonemas
Some people notice constipation, diarrhoea, wind, nausea or vomiting. Others have trouble or pain when swallowing, ulcers of the food pipe, headache, or pain in muscles and bones. Less often there may be rash, redness of the skin, or a short-term fall in blood calcium and phosphate. Reaction such as hives and swelling have been reported. Tell your doctor about any new or worsening symptoms, especially ones affecting swallowing or the chest.
Safety and precautions
Do not take Bonemas if you have problems with the food pipe that slow emptying, such as a stricture or achalasia, or if you cannot sit or stand upright for the time your doctor requires. It is not for people with low blood calcium or allergy to any ingredient. It should not be given to pregnant or breastfeeding women. Tell your doctor about stomach or swallowing problems, kidney problems, or other medicines you take, especially anti-inflammatory painkillers, aspirin, antacids or calcium. Ask your doctor before starting.
Frequently asked questions
What is Bonemas used for and what kind of medicine is it?
Bonemas is a bisphosphonate medicine used to treat osteoporosis in women after menopause. It slows the cells that break down bone, which helps increase bone mass and lowers the risk of hip and spine fractures. Your doctor will confirm whether it is suitable for you.
How should Bonemas be taken?
Your doctor decides the dose and how long you take Bonemas, so follow their instructions exactly. Swallow the tablet whole with plain water and stay upright as your doctor advises. Do not take it with antacids or calcium supplements. Ask your pharmacist for guidance if anything is unclear.
What does the dosage form and strength mean?
Bonemas comes as a tablet, which is a solid form you swallow. The strength is 70 mg, meaning each tablet contains 70 mg of alendronic acid. It is supplied in a 10's pack. Your doctor decides how the tablet fits into your treatment.
What is the price of Bonemas?
The listed price is ৳ 30.00. For the exact amount you pay, check with your pharmacy, as prices can differ between sellers. Your pharmacist can also advise on availability.
Treatment of Osteoporosis in Postmenopausal Women: Alendronic acid is indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, Alendronic acid increases bone mass and reduces the incidence of fractures, including those of the hip and spine.
... Read more
Alendronic acid is indicated for the-
Treatment of Osteoporosis in Postmenopausal Women: Alendronic acid is indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, Alendronic acid increases bone mass and reduces the incidence of fractures, including those of the hip and spine.
Prevention of Osteoporosis in Postmenopausal Women: Alendronic acid is indicated for the prevention of postmenopausal osteoporosis.
Treatment to Increase Bone Mass in Men with Osteoporosis: Alendronic acid is indicated for treatment to increase bone mass in men with osteoporosis.
Treatment of Glucocorticoid-Induced Osteoporosis: Alendronic acid is indicated for the treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density.
Treatment of Paget's Disease of Bone: Alendronic acid is indicated for the treatment of Paget’s disease of bone in men and women. Treatment is indicated in patients with Paget's disease of bone who have alkaline phosphatase at least two times the upper limit of normal, or those who are symptomatic, or those at risk for future complications from their disease.
Pharmacology
Alendronate is a bisphosphonate that binds to bone hydroxyapatite and specifically inhibits the activity of osteoclasts, the bone-resorbing cells. Alendronate reduces bone resorption with no direct effect on bone formation, although the latter process is ultimately reduced because bone resorption and formation are coupled during bone turnover.
Animal studies have indicated the following mode of action. At the cellular level, alendronate shows preferential localization to sites of bone resorption, specifically under osteoclasts. The osteoclasts adhere normally to the bone surface but lack the ruffled border that is indicative of active resorption. Alendronate does not interfere with osteoclast recruitment or attachment, but it does inhibit osteoclast activity. Studies in mice on the localization of radioactive [3H] alendronate in bone showed about 10-fold higher uptake on osteoclast surfaces than on osteoblast surfaces. Bones examined 6 and 49 days after [3H] alendronate administration in rats and mice, respectively, showed that normal bone was formed on top of the alendronate, which was incorporated inside the matrix. While incorporated in bone matrix, alendronate is not pharmacologically active. Thus, alendronate must be continuously administered to suppress osteoclasts on newly formed resorption surfaces. Histomorphometry in baboons and rats showed that alendronate treatment reduces bone turnover (i.e., the number of sites at which bone is remodeled). In addition, bone formation exceeds bone resorption at these remodeling sites, leading to progressive gains in bone mass.
Dosage & Administration
Treatment of Osteoporosis in Postmenopausal Women: The recommended dosage is one 70 mg tablet once weekly or one bottle of 70 mg oral solution once weekly or one 10 mg tablet once daily.
Prevention of Osteoporosis in Postmenopausal Women: The recommended dosage is one 35 mg tablet once weekly or one 5 mg tablet once daily.
Treatment to Increase Bone Mass in Men with Osteoporosis: The recommended dosage is one 70 mg tablet once weekly or one bottle of 70 mg oral solution once weekly or one 10 mg tablet once daily.
Treatment of Glucocorticoid-Induced Osteoporosis: The recommended dosage is one 5 mg tablet once daily, except for postmenopausal women not receiving estrogen, for whom the recommended dosage is one 10 mg tablet once daily.
Treatment of Paget's Disease of Bone: The recommended treatment regimen is 40 mg once a day for six months.
Interaction
The incidence of upper gastrointestinal side effects are increased with the concomitant use of non-steroidal anti-inflammatory agents and aspirin. Absorption of Alendronate is reduced in the presence of antacids and calcium supplements.
Contraindications
Alendronic acid is contraindicated in patients with the following conditions:
Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia.
Inability to stand or sit upright for at least 30 minutes.
Do not administer Alendronic acid oral solution to patients at increased risk of aspiration.
Hypocalcemia.
Hypersensitivity to any component of this product. Hypersensitivity reactions including urticaria and angioedema have been reported.
Side Effects
The commonest symptomatic side effects are constipation, diarrhoea, oesophageal ulcer, flatulence, dysphagia, musculoskeletal pain, headache, rarely rash, erythema, transient decrease in serum calcium and phosphate, nausea, vomiting, peptic ulceration, hypersensitivity reactions including urticaria and angio-oedema.
Pregnancy & Lactation
Alendronic acid should not be given to pregnant women or nursing mother.
Precautions & Warnings
Upper Gastrointestinal Adverse Reactions can occur. Instruct patients to follow dosing instructions. Discontinue if new or worsening symptoms occur.
Hypocalcemia can worsen and must be corrected prior to use.
Severe Bone, Joint, Muscle Pain may occur. Discontinue use if severe symptoms develop.
Osteonecrosis of the Jaw has been reported.
Atypical Femur Fractures have been reported. Patients with new thigh or groin pain should be evaluated to rule out an incomplete femoral fracture.
Storage Conditions
Store in a well-closed container at room temperature, 15-30°C
Alternative brands of Alendronic Acid
Other brands with the same generic name, cheapest first.